CBPD-409 is an orally active PROTAC degrader for CBP/p300, with DC50 of 0.2-0.4 nM. CBPD-409 exhibits antiproliferative effects in AR+ prostate cancer cell lines VCaP, LNCaP and 22Rv1, with IC50s of 1.2-2.0 nM. CBPD-409 exhibits antitumor efficacy (Red: CBP inhibitor GNE049 (HY-108435), Blue: CRBN/cullin 4A Thalidomide (HY-14658), Black: Linker)[1].
Molekulargewicht:
862.97
Reinheit:
99.38
CAS Nummer:
[3037549-86-0]
Formel:
C46H52F2N10O5
Target-Kategorie:
Histone Acetyltransferase,PROTACs
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten